NCT06525805

Brief Summary

The present randomized controlled trial (RCT) was designed to investigate the perceptions of researchers on systematic review (SR) abstracts. The primary objective will be to compare readers' attention of shorter versus longer abstracts. The secondary objective will be to assess the perception of an abstract based on four indicators of a well-written abstract: (a) Informativeness, (b) Accuracy, (c) Attractiveness, and (d) Conciseness. The study will involve researchers from all over the world who recently published an SR, regardless of their research field. To identify eligible authors, a search of MEDLINE (via PubMed) was conducted on May 5, 2024, for systematic reviews published between January 1, 2024, and March 26, 2024. A total of at least 6200 SRs will be selected from PubMed and assessed for eligibility. The corresponding author information will be extracted from all included SRs and randomized in a 1:1 ratio.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,941

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

2 months

First QC Date

July 18, 2024

Last Update Submit

November 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Trial participation

    The primary outcome of this RCT will be the trial participation, which is defined as the proportion of participants who read the abstract and then clicked on the "Continue" button. This will be quantified by dividing the number of participants who read the abstract and proceeded to complete the survey by the total number of individuals who clicked on the link in the email. Information will be electronically captured in SoSci survey.

    Immediately after reading the abstract

Secondary Outcomes (1)

  • Indicators of a well-written abstract

    Immediately after reading the abstract

Other Outcomes (1)

  • Time needed to read the abstract

    Immediately after reading the abstract

Study Arms (2)

Long Abstract

EXPERIMENTAL

Abstract length: 771 words

Other: Long Abstract

Short Abstract

ACTIVE COMPARATOR

Abstract length: 277 words

Other: Short Abstract

Interventions

The intervention and control group will be provided with a structured abstract of the review by Soderberg et al., entitled "Percutaneous nephrolithotomy vs. retrograde intrarenal surgery for renal stones". This review was published once in the Cochrane Database of Systematic Reviews and once in the journal BJU International. The length of the abstract differs significantly depending on the journal. The participants assigned to this study arm will be presented with the longer version published in the Cochrane Database, comprising 771 words (PMID: 37955353).

Long Abstract

The participants assigned to this study arm will be presented with the shorter version published in BJU International, comprising 277 words (PMID: 37942649).

Short Abstract

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Systematic reviews of all types

You may not qualify if:

  • No English abstract
  • Other types of evidence syntheses (e.g. scoping reviews, methodological papers)
  • Protocols
  • Editorials
  • Others: e.g. Corrections, retractions, erratums, or summaries of SRs
  • No email address available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carl von Ossietzky Universität Oldenburg

Oldenburg, Germany

Location

Related Publications (5)

  • Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. The Principles of Biomedical Scientific Writing: Abstract and Keywords. Int J Endocrinol Metab. 2020 Jan 28;18(1):e100159. doi: 10.5812/ijem.100159. eCollection 2020 Jan.

    PMID: 32308700BACKGROUND
  • Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018 Jan 10;18(1):5. doi: 10.1186/s12874-017-0468-4.

    PMID: 29316881BACKGROUND
  • Soderberg L, Ergun O, Ding M, Parker R, Borofsky MS, Pais V, Dahm P. Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults. Cochrane Database Syst Rev. 2023 Nov 13;11(11):CD013445. doi: 10.1002/14651858.CD013445.pub2.

    PMID: 37955353BACKGROUND
  • Soderberg L, Ergun O, Ding M, Parker R, Borofsky M, Pais V, Dahm P. Percutaneous nephrolithotomy vs retrograde intrarenal surgery for renal stones: a Cochrane Review. BJU Int. 2024 Feb;133(2):132-140. doi: 10.1111/bju.16220. Epub 2023 Nov 29.

    PMID: 37942649BACKGROUND
  • Helbach J, Wandscher K, Pieper D, Hoffmann F. Readers' attention to shorter versus longer abstracts of systematic reviews: a randomised controlled trial. BMJ Evid Based Med. 2025 Oct 17:bmjebm-2024-113613. doi: 10.1136/bmjebm-2024-113613. Online ahead of print.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants will be blinded to the intervention. In the cover letter, participants will be informed that the study aims to examine the characteristics of an abstract. However, they will not be informed that the primary focus of this study is the influence of the abstract´s length. Furthermore, the participants will be not aware of the number of different abstracts that were randomly allocated.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This will be a two-arm, single-blinded, superiority, parallel-group randomized controlled trial (RCT) with 1:1 allocation of intervention and control groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2024

First Posted

July 29, 2024

Study Start

August 1, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

November 8, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations